Japanese researchers proved in a recent investigation the link
between a common germ and cancer. In their landmark study, germ
elimination greatly reduced the risk of tumor recurrence after stomach
cancer surgery. Also a cause of peptic ulcer, the culprit known as Helicobacter pylori is believed to cause malignancy of the stomach.
The researchers evaluated cancer recurrence of 544 patients who previously went under the knife for early stomach cancer. Half of the patients received H. pylori regimen (eradication group) that consist of amoxicillin, clarithromycin and lansoprazole. The other half received standard care with no H. pylori treatment (control group).
After three years, 24 patients in the control group and nine patients in the eradication group developed new lesions. Taking into account age, gender, type and location of tumor and other factors, it was concluded that eradicating the germ reduced the risk of cancer recurrence by approximately 65 percent. The researchers recommended that prophylactic H. pylori eradication regimen after surgery for early stomach malignancy be used to prevent tumor recurrence.
The researchers evaluated cancer recurrence of 544 patients who previously went under the knife for early stomach cancer. Half of the patients received H. pylori regimen (eradication group) that consist of amoxicillin, clarithromycin and lansoprazole. The other half received standard care with no H. pylori treatment (control group).
After three years, 24 patients in the control group and nine patients in the eradication group developed new lesions. Taking into account age, gender, type and location of tumor and other factors, it was concluded that eradicating the germ reduced the risk of cancer recurrence by approximately 65 percent. The researchers recommended that prophylactic H. pylori eradication regimen after surgery for early stomach malignancy be used to prevent tumor recurrence.